FORMA Therapeutics and Cancer Research Technology Form Two Virtual Companies to Advance Deubiquitination Assets

| March 23, 2015 | 0 Comments

FORMA Therapeutics and Cancer Research Technology, Ltd. announced today the formation of two new virtual Asset Discovery and Development Companies with novel chemical matter targeting undisclosed deubiquitinating enzymes .

Read this article:
FORMA Therapeutics and Cancer Research Technology Form Two Virtual Companies to Advance Deubiquitination Assets

Tags: , , , , , , , ,

Category: Recent News

About the Author ()

Leave a Reply